Tin tức & Cập nhật

Ivermectin falls flat against mild-to-moderate COVID-19

08 Mar 2025

Treatment with ivermectin for mild-to-moderate COVID-19 does not appear to reduce recovery time as compared with placebo, according to data from the ongoing ACTIV-6* study.

Ivermectin falls flat against mild-to-moderate COVID-19

08 Mar 2025

High-dose sulbactam tied to greater Cmid, PK-PD achievement

07 Mar 2025

Treatment with high-dose sulbactam leads to higher mid-dosing (Cmid) and pharmacokinetic-pharmacodynamic (PK-PD) achievement in paediatric patients, reports a study.

High-dose sulbactam tied to greater Cmid, PK-PD achievement

07 Mar 2025

Cabozantinib plus ipilimumab/nivolumab fails to meet efficacy target in thyroid cancer

07 Mar 2025

Treatment with cabozantinib in combination with nivolumab and ipilimumab (CaboNivoIpi) results in low objective response rates (ORRs) and a high rate of grade ≥3 treatment-related adverse events (AEs) among patients with previously treated advanced differentiated thyroid cancer, reveals a recent study.

Cabozantinib plus ipilimumab/nivolumab fails to meet efficacy target in thyroid cancer

07 Mar 2025

Adjunctive intra-arterial lytics bounce back in ANGEL-TNK, PEARL trials

07 Mar 2025 bởi

Two trials presented at ISC 2025 support intra-arterial thrombolysis as an adjunct to stroke thrombectomy in patients with large-vessel occlusions (LVOs).

Adjunctive intra-arterial lytics bounce back in ANGEL-TNK, PEARL trials

07 Mar 2025

Foetal malformation risk high in ART-conceived pregnancies of women with epilepsy

06 Mar 2025

Conception via assisted reproductive technology (ART) carries an increased risk of foetal malformation among women with epilepsy, according to a study.

Foetal malformation risk high in ART-conceived pregnancies of women with epilepsy

06 Mar 2025

COVID-19 ups AIBD risk, but vaccination helps

06 Mar 2025 bởi

Individuals with COVID-19 infection are at higher risk of autoimmune blistering disease (AIBD), but vaccination helps reduce such risk, suggests a study.

COVID-19 ups AIBD risk, but vaccination helps

06 Mar 2025

Two- vs one-bag method: Which works best for DKA treatment?

06 Mar 2025

Implementation of the two-bag method for the management of diabetic ketoacidosis (DKA) has improved safety and efficacy outcomes when compared with the one-bag method, according to a study.

Two- vs one-bag method: Which works best for DKA treatment?

06 Mar 2025

Tislelizumab a new Tx alternative for very high-risk bladder cancer?

06 Mar 2025 bởi

In the phase II pilot TRUCE-02 trial, tislelizumab plus low-dose nab-paclitaxel shows promising clinical antitumour activity and is well tolerated in patients with extensive very high-risk (VHR) non-muscle-invasive bladder cancer (NMIBC) who are ineligible for or decline radical cystectomy (RC).

Tislelizumab a new Tx alternative for very high-risk bladder cancer?

06 Mar 2025

Immune changes, persistent spike protein seen in people with PVS

06 Mar 2025 bởi

People with post-vaccination syndrome (PVS), a rare condition following receipt of COVID-19 jabs, exhibit distinct immunological patterns, including the reappearance of the dormant Epstein-Barr virus (EBV) and persistence of SARS-CoV-2 spike protein in the blood, according to new research.

Immune changes, persistent spike protein seen in people with PVS

06 Mar 2025

Shorter duration, larger lesion predict treatment failure with 5-FU 5% cream

05 Mar 2025

Treatment with 5-fluorouracil (5-FU) 5% cream tends to end in failure with shorter treatment duration and larger lesion size in patients with squamous cell carcinoma in situ (SCCis), a study has shown.

Shorter duration, larger lesion predict treatment failure with 5-FU 5% cream

05 Mar 2025

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

Ivermectin falls flat against mild-to-moderate COVID-19

Ivermectin falls flat against mild-to-moderate COVID-19

High-dose sulbactam tied to greater Cmid, PK-PD achievement

High-dose sulbactam tied to greater Cmid, PK-PD achievement

Cabozantinib plus ipilimumab/nivolumab fails to meet efficacy target in thyroid cancer

Cabozantinib plus ipilimumab/nivolumab fails to meet efficacy target in thyroid cancer

Adjunctive intra-arterial lytics bounce back in ANGEL-TNK, PEARL trials

Adjunctive intra-arterial lytics bounce back in ANGEL-TNK, PEARL trials

Foetal malformation risk high in ART-conceived pregnancies of women with epilepsy

Foetal malformation risk high in ART-conceived pregnancies of women with epilepsy

COVID-19 ups AIBD risk, but vaccination helps

COVID-19 ups AIBD risk, but vaccination helps

Two- vs one-bag method: Which works best for DKA treatment?

Two- vs one-bag method: Which works best for DKA treatment?

Tislelizumab a new Tx alternative for very high-risk bladder cancer?

Tislelizumab a new Tx alternative for very high-risk bladder cancer?

Immune changes, persistent spike protein seen in people with PVS

Immune changes, persistent spike protein seen in people with PVS

Shorter duration, larger lesion predict treatment failure with 5-FU 5% cream

Shorter duration, larger lesion predict treatment failure with 5-FU 5% cream